Similar articles

• Pathological gambling in Parkinson's disease.

  Stocchi F. Stocchi F. Lancet Neurol. 2005 Oct;4(10):590-2. doi: 10.1016/S1474-4422(05)70177-0. Lancet Neurol. 2005. PMID: 16168925 No abstract available.
• Are there clinically significant differences between dopamine agonists.

  Stocchi F, Vacca L, Onofrj M. Stocchi F, et al. Adv Neurol. 2003;91:259-66. Adv Neurol. 2003. PMID: 12442684 Review. No abstract available.
• Sleep disorders in Parkinson's disease.

  Larsen JP. Larsen JP. Adv Neurol. 2003;91:329-34. Adv Neurol. 2003. PMID: 12442690 Review. No abstract available.
• Medications for Parkinson's disease.

  Whitney CM. Whitney CM. Neurologist. 2007 Nov;13(6):387-8. doi: 10.1097/NRL.0b013e318158e47d. Neurologist. 2007. PMID: 18090719 No abstract available.
• Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease?

  Kish SJ. Kish SJ. Adv Neurol. 2003;91:39-49. Adv Neurol. 2003. PMID: 12442662 Review. No abstract available.